Category Uncategorized

GIOS is heading to PSDI 2025

We’re exited to share that GIOS Biostructures will be present at the Protein Structure Determination in Industry (PSDI) 2025 conference. A premier event bringing together leading minds in structural biology, biophysics, and drug discovery. Join us as we connect, collaborate…

Design. Predict. Validate. Realize. The MESO™ Advantage.

GIOS MESO™ Platform

Protein design/engineering has entered a new era, fueled by the rise of reliable AI-based methods. This shift has transformed the design process into a powerful loop of scaffold generation, sequence prediction, and structural validation.🔹 Scaffold generation allows us to create…

Fragment-based screening — big impact from small molecules

X-ray Fragment Screening

Fragment-based screening is a powerful approach to early-stage drug discovery, using small, well-soluble organic molecules to efficiently explore chemical space. Thanks to their simplicity and affordability, fragment libraries are accessible even to the smallest biotech companies. Traditionally, fragments are screened…

From protein to structure — precision at every step

Crystallography Pipeline

At GIOS Biostructures, we take purified proteins and deliver high-resolution 3D structures through our automated crystallography platform and synchrotron access. From crystallization screening and optimization to X-ray data collection and structure refinement, every step is designed for speed, accuracy, and…

Welcome to GIOS Biostructures!

GIOS Biostructures

We’re thrilled to announce the official launch of GIOS Biostructures, a new CRO dedicated to solving structural biology problems of our customers. Based in Belgium, we’re here to bring our expertise and provide services to the biochemistry and pharmacology companies…